Trial intelligence / Profile preview

Trivalent Inactivated Influenza Vaccine in Pregnant Malian Women

NCT01430689Phase 4Completed

Sponsor
University of Maryland, Baltimore
Start
Sep 2011
Primary completion
Jan 2014
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of influenza vaccine in influenza (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Number of infants with influenza whose mothers received vaccine at any time during the 3rd trimester at 2 years. Started Sep 2011; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01430689.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01430689.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call